The Elderlye-COBAHLTNCT02155686
Elderly Chronic Diseases Online Biometric Analysis Home Living Technology
A study testing Biosensors and Home automation in people with The Elderly, run by University Hospital, Limoges at 1 site in France.
Trial summary
The elderly or people with disabilities want to remain in their homes even when their health condition has been getting worse. This project aims to demonstrate that home automation and telemonitoring can lead to develop a home safety environment that could help the elderly and individual with disability live… Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- The Elderly
- What is being tested?
- Biosensors and Home automation
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 536 participants
- Where
- 1 siteFrance
- Study dates
- 27 Aug 2014to 1 Jan 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- Aged 65 or more.
- House equipped with home automation
- Having been hospitalized in the year prior to the inclusion for the following conditions : heart failure, chronic obstructive pulmonary disease (COPD ), diabetes, high blood pressure ( hypertension ) , repetitive falls, chronic renal failure , stroke, neurodegenerative diseases , malnutrition (according to criteria HAS)
- Multiple chronic diseases (at least 2 comorbidities) .
- Having given free and informed consent
Who cannot join
- Life expectancy less than 12 months
- Enrolled in another clinical trial
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Etude de l'Impact Clinique de la télésurveillance à Domicile Par télémédecine de paramètres biométriques de la Personne âgée Polypathologique
The elderly or people with disabilities want to remain in their homes even when their health condition has been getting worse.
This project aims to demonstrate that home automation and telemonitoring can lead to develop a home safety environment that could help the elderly and individual with disability live independently in their own home.
Read more
In this study, the automation sensors containing devices follow up chronic disease clinical factors to monitor their biometrical parameters and detect any abnormal prodromal disease decompensation via telemonitoring and geriatric expertise.
The purpose of this study is:
- to provide clinical evidence of the effectiveness of automation tools and telemonitoring/expertise for the home support for people at risk of loss of autonomy
- to demonstrate the clinical benefit of combining the automation and telemonitoring and geriatric teleexpertise
- Conditions
- The Elderly
- Being tested
- Biosensors, Home automation
- Keywords
- Elderly, Prevention, Multiple chronic disease, Telemonitoring, Geriatric teleexpertise, Home heath care, Medico-economics
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BiosensorsDevice
Device: Biometric sensors; Home automation; telecare
Home automationDevice
| Study group | Role | What they receive |
|---|---|---|
| Biosensors | Experimental | Participants in this arm are equipped both with home telecare/automation and with biometric sensors Receives: Device: Biosensors; Device: Home automation |
| Automation | Active comparator | Participants in this arm are equiepd with home automation only Receives: Device: Home automation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of unplanned hospitalization for decompensation
The effectiveness of home telemonitoring on the cumulative incidence of unplanned hospitalization for decompensation in the elderly
Measured: at 12 months
Secondary outcomes (2)
Impact on global health
- Number of visits to the emergency
- Number of readmissions
- Number of days of hospitalization
- Number of visits to the doctor
Measured: at 12 months
Cost/effectivness preventive care
Evaluate the cost / effectiveness of the impact of telemonitoring on the preventive care in the elderly
Measured: at 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Jun 2014 (estimated)
- Study start27 Aug 2014
- Primary completion9 Sep 2018
- Study completion1 Jan 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for The ElderlyStudies of the same condition, open and under way.
- More trials run by University Hospital, LimogesThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 536 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Limoges
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Thierry DANTOINE, MD, Study chair, CHU Limoges
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02155686
- Sponsor's protocol ID
- I13027
- Acronym
- e-COBAHLT
- Status last verified
- Jan 2019
- First submitted
- 24 May 2014
- Last updated
- 27 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
Publications
Tchalla A, Marchesseau D, Cardinaud N, Laubarie-Mouret C, Mergans T, Kajeu PJ, Luce S, Friocourt P, Tsala-Effa D, Tovena I, Preux PM, Gayot C. Effectiveness of a home-based telesurveillance program in reducing hospital readmissions in older patients with chronic disease: The eCOBAHLT randomized controlled trial. J Telemed Telecare. 2025 Feb;31(2):231-238. doi: 10.1177/1357633X231174488. Epub 2023 May 23.
PubMed 37221865
Study at a glance
From the registry record, last updated by the sponsor on 27 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Etude de l'Impact Clinique de la télésurveillance à Domicile Par télémédecine de paramètres biométriques de la Personne âgée Polypathologique
- ClinicalTrials.gov ID
- NCT02155686
- Acronym / sponsor ID
- e-COBAHLT / I13027
- Conditions
- The Elderly
- Keywords
- Elderly, Prevention, Multiple chronic disease, Telemonitoring, Geriatric teleexpertise, Home heath care, Medico-economics
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 536 participants (actual)
- Lead sponsor
- University Hospital, LimogesUniversity, hospital or other
- Study start
- 27 Aug 2014 (actual)
- Primary completion
- 9 Sep 2018 (actual)
- Study completion
- 1 Jan 2019 (actual)
- First posted
- 4 Jun 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The elderly or people with disabilities want to remain in their homes even when their health condition has been getting worse.
This project aims to demonstrate that home automation and telemonitoring can lead to develop a home safety environment that could help the elderly and individual with disability live independently in their own home.
In this study, the automation sensors containing devices follow up chronic disease clinical factors to monitor their biometrical parameters and detect any abnormal prodromal disease decompensation via telemonitoring and geriatric expertise.
The purpose of this study is:
- to provide clinical evidence of the effectiveness of automation tools and telemonitoring/expertise for the home support for people at risk of loss of autonomy
- to demonstrate the clinical benefit of combining the automation and telemonitoring and geriatric teleexpertise
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Biosensors | Experimental | Device: Biosensors, Device: Home automationParticipants in this arm are equipped both with home telecare/automation and with biometric sensors |
| Automation | Active comparator | Device: Home automationParticipants in this arm are equiepd with home automation only |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (5 listed)
- Aged 65 or more.
- House equipped with home automation
- Having been hospitalized in the year prior to the inclusion for the following conditions : heart failure, chronic obstructive pulmonary disease (COPD ), diabetes, high blood pressure ( hypertension ) , repetitive falls, chronic renal failure , stroke, neurodegenerative diseases , malnutrition (according to criteria HAS)
- Multiple chronic diseases (at least 2 comorbidities) .
- Having given free and informed consent
Key exclusion criteria (2 listed)
- Life expectancy less than 12 months
- Enrolled in another clinical trial
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BiosensorsDevice: Biometric sensors; Home automation; telecare | Device | Biosensors |
| Home automation | Device | Automation, Biosensors |
Primary outcome
Number of unplanned hospitalization for decompensation
Time frame: at 12 months
The effectiveness of home telemonitoring on the cumulative incidence of unplanned hospitalization for decompensation in the elderly
2 secondary outcomes
Impact on global health
Time frame: at 12 months
Cost/effectivness preventive care
Time frame: at 12 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Mar 2026.
- Results publication: PubMed 37221865Tchalla A, Marchesseau D, Cardinaud N, Laubarie-Mouret C, Mergans T, Kajeu PJ, Luce S, Friocourt P, Tsala-Effa D, Tovena I, Preux PM, Gayot C. Effectiveness of a home-based telesurveillance program in reducing hospital readmissions in older patients with chronic disease: The eCOBAHLT randomized controlled trial. J Telemed Telecare. 2025 Feb;31(2):231-238. doi: 10.1177/1357633X231174488. Epub 2023 May 23.
- ResultsLink provided by the sponsor.
Related trials for The Elderly
Active, not recruitingObservational study
A Study to Learn About the Safety of PREVENAR 20 Vaccine in Infants Aged Between Two to Six Months
Pneumococcal Disease
RecruitingPhase 3
A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
RecruitingPhase 3
A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
Chondral Defect, Articular Cartilage Defect
RecruitingObservational study
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Colorectal Cancer, Sarcopenia
RecruitingPhase 3
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Atopic Dermatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Thierry DANTOINE, MD study chair
CHU Limoges
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Biosensors and Home automation in people with The Elderly, run by University Hospital, Limoges at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of unplanned hospitalization for decompensation (time frame: at 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02155686, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2026.